2.185
Zentalis Pharmaceuticals Inc Azioni (ZNTL) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Operating Expenses |
17.27%
44.39
|
37.85 | 37.39 | 33.73 | 36.06 |
| Operating Income/Loss |
17.27%
-44.39
|
-37.85 | -37.39 | -33.73 | -36.06 |
| Income/Loss From Continuing Operations Before Tax |
19.63%
-42.15
|
-35.23 | -34.77 | -26.69 | -26.87 |
| Income Tax Expense/Benefit |
15.00%
0.138
|
0.12 | 0.442 | - | - |
| Net Income/Loss |
19.61%
-42.29
|
-35.35 | -35.22 | -26.69 | -26.87 |
| Basic Average Shares |
1.51%
71.33
|
70.26 | - | 72.14 | 71.99 |
| Diluted Average Shares |
1.51%
71.33
|
70.26 | - | 72.14 | 71.99 |
| Basic Earnings Per Share |
18.00%
-0.59
|
-0.50 | - | -0.37 | -0.37 |
| Diluted Earnings Per Share |
18.00%
-0.59
|
-0.50 | - | -0.37 | -0.37 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):